In our October issue of Pharmaceutical Executive
FEATURES
Cover Story
EMA's Hans-Georg Eichler: Europe's Man with a Plan
Leela Barham
In the midst of a leadership vacuum at the European Medicines Agency (EMA), Pharm Exec talks with the organization's top medical officer, Hans-Georg Eichler, about its potentially game-changing drug approval program—one designed to balance safety requirements with faster patient access to the strong science now emerging from industry labs. |
From the Editor
Competition: The Best Defense
William Looney
A new and more compelling strategy must be crafted to engage critics on drug pricing and bolster biopharmaceuticals as a leader in technological innovations that lower health costs overall. |
Legal
Knowledge is Value: Navigating Biopharma's New IP Terrain
William Looney
With GE's blueprint for effective IP engagement as a guide, this Q&A explores how life sciences companies are using IP as a GPS to market relevance. |
Technology
Rewriting the Book of Life: A New Era in Precision Gene Editing
Elsy Boglioli, Magali Richard
Advances in gene-editing technology have the potential to fundamentally reshape vital treatments for patients. The path of progress, however, will hinge on the ability of drugmakers to choose the right technology and partner. |
Competitive Advantage
Competitive Trial Management: Winning with Clinical Studies
Stan Bernard
Savvy companies are leveraging clinical trials as competitive weapons in the larger brand wars.
|
 |
ALSO IN THIS ISSUE
Rita Hayworth and Alzheimer's Redemption
Julian Upton
With next month designated National Alzheimer's Disease and Awareness Month in the US, Julian Upton looks at the film star whose plight pushed the long-misunderstood disorder into the spotlight.
Tablet Innovation: Sizing Up the Value
Thomas Hein
The rising focus on tablet and capsule administration woes may spell potential new revenue opportunities for industry.
Biosimilars, Patent Issues Dominate Political Agenda
Jill Wechsler
Managing the nomination of new commissioner added to a packed FDA agenda last month.
Drug Pricing in Europe: Small Steps Toward Big Changes
Reflector
Adoption of joint procurement agreement signals new effort from EU to better understand drug pricing issues.
|
| |
| WEBCASTS |
| New Tufts CSDD Research: Industry Adoption of eClinical Solutions and CDISC Standards
|
| The Growing Aging Consumer Population – Living Longer, Living Smarter |
Engineer Your Business to Win in the Mobile Selling Moment
|
| |
